BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2995515)

  • 1. [Experimental chemotherapy of ovarian cancers heterotransplanted in nude mice].
    Sawada M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Aug; 37(8):1400-8. PubMed ID: 2995515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of post operative maintenance chemotherapy against ovarian cancer].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1115-20. PubMed ID: 3611882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A series of malignant ovarian cancers arising from within a mature cystic teratoma: a single institution experience.
    Black JD; Roque DM; Pasternak MC; Buza N; Rutherford TJ; Schwartz PE; McCarthy S; Ratner E
    Int J Gynecol Cancer; 2015 Jun; 25(5):792-7. PubMed ID: 25790042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Oranratanaphan S; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growing Teratoma Syndrome After Chemotherapy For Ovarian Immature Teratoma.
    Imran H; Siddiqui AH; Wilson F; Pashankar F
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e630-e633. PubMed ID: 31205224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
    Sato S; Itamochi H; Kigawa J; Oishi T; Shimada M; Sato S; Naniwa J; Uegaki K; Nonaka M; Terakawa N
    Cancer Sci; 2009 Mar; 100(3):546-51. PubMed ID: 19154404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Fluorouracil (5-FU) and leucovorin in women with heavily pretreated advanced ovarian carcinoma.
    Peled Y; Levavi H; Krissi H; Weill Y; Sabah G; Eitan R
    Am J Clin Oncol; 2013 Oct; 36(5):472-4. PubMed ID: 22706176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a new ovarian tumor line in nude mice and its application to treatment of the donor patient.
    Sawada M; Matsui Y; Okudaira Y
    Gynecol Oncol; 1985 Jul; 21(3):320-30. PubMed ID: 4007611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery.
    Tanaka T; Toujima S; Utsunomiya T; Yukawa K; Umesaki N
    Oncol Rep; 2008 Jul; 20(1):13-23. PubMed ID: 18575713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo.
    Liu P; Mao H; Hou P
    Int J Gynecol Cancer; 2006; 16(2):538-48. PubMed ID: 16681723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined pegylated liposomal doxorubicin and carboplatin in the treatment of recurrent epithelial ovarian cancer].
    Zheng H; Gao YN; Jiang GQ; Gao M; Wang W; Yan X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):839-42. PubMed ID: 19087568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroconversion of malignant immature teratomas of the ovary after chemotherapy.
    Aronowitz J; Estrada R; Lynch R; Kaplan AL
    Gynecol Oncol; 1983 Dec; 16(3):414-21. PubMed ID: 6654184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant tumors associated with ovarian mature teratoma: A single institution experience.
    Trabzonlu L; Durmaz G; Vural C; Muezzinoglu B; Corakci A
    Pathol Res Pract; 2017 May; 213(5):518-521. PubMed ID: 28214217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytostatic treatment of pseudomyxoma peritonei].
    Schneider T; Lotze W
    Zentralbl Gynakol; 1985; 107(24):1525-7. PubMed ID: 3004068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-cancer drug sensitivity test against human testicular cancer xenograft--comparison with clinical results of chemotherapy].
    Miki T; Kotake T
    Hinyokika Kiyo; 1988 Nov; 34(11):1903-9. PubMed ID: 3242364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of yolk sac tumor heterotransplanted to nude mice (author's transl)].
    Sawada M; Hayakawa K; Matsui Y; Nishiura H; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1596-602. PubMed ID: 7240825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Mucinous ovarian cancer.
    Omura GA
    Gynecol Oncol; 2005 Dec; 99(3):789; author reply 789-90. PubMed ID: 16125757
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synchronous double cancers in the ovary and kidney--a case report].
    Myoga H; Tamaki M; Shinko Y; Ohta S; Shigemasa K; Nogawa T; Katsube Y; Fujiwara A
    Gan No Rinsho; 1988 Nov; 34(14):2007-14. PubMed ID: 2849689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of ovarian cancer. New approaches to treatment.
    Smith JP; Rutledge F; Wharton JT
    Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.